Betatinib 100mg Capsule

About

Betatinib 100mg Capsule is an oral small-molecule tyrosine kinase inhibitor (TKI) designed to selectively target specific receptor tyrosine kinases involved in cell growth, proliferation, and survival pathways. By inhibiting these aberrant signaling pathways, Betatinib can suppress tumor cell growth and induce apoptosis in various malignancies. Its mechanism of action focuses on disrupting the intracellular signaling cascades that drive cancer progression, offering a targeted therapeutic approach. This selective inhibition helps to prevent the uncontrolled cell division characteristic of cancer, leading to a reduction in tumor burden and improved disease control. It represents a significant advancement in personalized cancer therapy, particularly for patients with specific genetic mutations.

Uses

• Specific types of solid tumors
• Certain hematological malignancies
• Advanced or metastatic cancers
• When other treatments have failed

Directions For Use

Take orally once daily with or without food, as directed by your oncologist. Swallow the capsule whole.

Benefits

• Targets specific cancer pathways
• Oral administration for convenience
• May improve progression-free survival
• Reduces tumor burden
• Potential for fewer systemic side effects than traditional chemotherapy
• Offers a targeted treatment option

Side Effects

• Diarrhea
• Nausea
• Vomiting
• Fatigue
• Rash
• Hand-foot syndrome
• Hypertension
• Elevated liver enzymes
• Headache
• Anorexia
• Stomatitis
• Thrombocytopenia

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it may exacerbate gastrointestinal side effects or liver toxicity.
• Pregnancy - Contraindicated in pregnancy; use effective contraception during and for a period after treatment.
• Breastfeeding - Not recommended; discontinue breastfeeding during treatment due to potential harm to the infant.
• Liver - Use with caution in patients with hepatic impairment; dose adjustments and close monitoring of liver function are required.
• Kidney - Use with caution in patients with renal impairment; dose adjustments may be necessary based on kidney function.
• Lung - Monitor for interstitial lung disease (ILD) or pneumonitis, which can be serious adverse events.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.